4 June 2024 in Health Science Reports
Background and Aims: This study presents a comprehensive overview of a well‐recognized critical pathogen Acinetobacter baumannii and demonstrates the potential of artificial intelligence (AI) in discovering new antibiotics. It is well‐known for causing serious infections, especially in patients admitted to intensive care units, which is further compromised by bacterium's resistance to even last‐resort antibiotics like carbapenems, posing critical challenges in its treatment and eradication. This article discusses Abaucin, a revolutionary antibiotic created from artificial intelligence, as a creative and potential treatment for A. baumannii.Methods: A comprehensive literature search was conducted using various databases including PubMed, Google Scholar, Cochrane, Science Direct, MEDLINE. Only articles written in English were considered. This correspondence was written after a thorough evaluation of all the articles that discussed Abaucin's discovery, potency against A. baumannii, and the potential of AI in discovering new antibiotics. In addition, references from the selected articles were also examined to ensure a comprehensive review of the literature.Results: This article highlights the discovery of a novel AI‐derived antibiotic, Abaucin that offers a promising solution for A. baumannii infections. Abaucin has a narrow range of action that minimizes the risk of inter‐pathogen spread of resistance, making the drug more appealing and effective. Its potential to suppress wound infections caused by multidrug‐resistant A. baumannii paves a hope for the eradication of superbugs. Further investigation and trials are needed to determine its effectiveness in human subjects and its integrity in the clinical workflow. machine learning (ML) and precision approach could revolutionize treatment strategies.Conclusion: The discovery of Abaucin as an antibiotic to combat drug‐resistant A. baumannii bacteria showcases AI and ML's potential to uncover novel antibiotics, thereby offering alternative treatment options. This novel inception of the AI‐derived antibiotic, Abaucin marks the first step in introducing an innovative treatment option and represents a substantial leap in the treatment of drug‐resistant illnesses and the use of AI in medical advancements.
7 August 2023 in Annals of Biomedical Engineering
27 April 2024 in Archives of Gynecology and Obstetrics
1 January 2024 in Environmental Health Insights
Climate change represents an unprecedented global public health crisis with extensive and profound implications. The Lancet Commission identified it as the foremost health challenge of the 21st century. In 2015, air pollution alone caused approximately 9 million premature deaths worldwide. Climate change also exacerbates extreme weather events, displacement, mental health disorders, disease vectors, food insecurity, and malnutrition, particularly impacting vulnerable developing countries like Pakistan due to its agricultural reliance, diverse topography, and limited resources. This study assesses Pakistani medical students’ perceptions of climate change’s health impacts. Conducted in February 2024, a cross-sectional survey of 632 students using a standardized questionnaire was employed via online Google Forms. The questionnaire was validated and an Exploratory Factor Analysis identified seven subscales of environmental health consciousness. The mean participant age was 21.17 years, with a balanced gender distribution. Students showed high environmental health consciousness (Mean = 35.6, SD = 5.2), with 88% attributing climate change to human activities and 89.1% anticipating serious future health impacts. Significant concerns included air quality-related illness (91%), water-availability illness (86%), healthcare disruption (85%), cold-related illness (83%), and flooding-related displacement (87%). Psychological impacts were acknowledged by 68%. Household income, age, and gender were significant predictors. These results highlight the need for integrating climate change and health education into medical curricula to prepare future healthcare providers.
9 February 2024 in Health Science Reports
Background and Aims: Poliomyelitis is an acute neurologic condition that causes muscle weakness, permanent flaccid paralysis, and even death. The world has seen a drastic fall in the number of poliovirus cases owing to effective immunization programs and preventive measures. Pakistan and Afghanistan still remain the two endemic countries for poliovirus, particularly, the WPV1 strain. Global Polio Eradication Initiative (GPEI) has set a target to eradicate all WPV1 cases by the end of 2023. However, the re‐emergence of WPV1 cases has posed a serious setback for the achievement of this target. This article aims to discuss the public health challenges that contribute to resurgence of poliovirus cases. Methods: A comprehensive literature search was conducted using various databases including Cochrane, Google Scholar, PubMed, Science Direct, MEDLINE. Only articles written in English were considered. All the articles reporting the incidence of poliovirus and WPV1 cases in Pakistan, surveillance data and global context of poliovirus outbreak were evaluated to write this correspondence. In addition, references from the selected articles were also examined to ensure a comprehensive review of the literature. Results: This article highlights the factors contributing to the re‐emergence of WPV1 cases in Pakistan. Low vaccine coverage, attacks on frontline polio health workers, misinformation, and reluctance to vaccine acceptance pose a daunting challenge for polio eradication. Further, gaps in AFP surveillance and sensitivity may underestimate the true extent of the emerging genetic clusters. The Covid‐19 pandemic and subsequent flooding in the affected area have further worsened the underdeveloped public health infrastructure. Conclusion: Despite the challenges, the country has observed a significant decline in the number of cases in the past 2 years. It is high time to capitalize on the decrease in WPV1 cases by intensifying the efforts to mitigate and limit the spread of the disease.
24 August 2023 in Health Science Reports
Background and Aims: Dry Eye Disease (DED) is a multifactorial chronic inflammatory condition of the corneal surface, attributed to insufficient or low‐quality production of tears, accounting for 5‐50% of the cases globally. Artificial tears are the first line of treatment as they reduce ocular surface tension, and improve film stability and optical quality. EzriCare Artificial Tears are preservative‐free, multi‐dose, readily accessible eye drops containing carboxymethylcellulose sodium solution (10 mg in 1 ml) aiming for relief against DED. This article discusses the public health challenges faced by the use of EzriCare Artificial Tears and emphasizes the need for alternative therapies for the effective management of DED.Methods: We searched for articles documenting the incidence of the current multi‐drug resistant P. aeruginosa strain outbreak caused by the use of preservative‐free artificial tears and the challenges faced through the use of artificial tears on PubMed, and Google Scholar.Results: EzriCare and other preservative‐free artificial tears have been reported to pose a serious public health risk as they have been found to be the commonly used product among the people infected with the current multi‐state outbreak of the multi‐drug resistant P. aeruginosa strain.Conclusion: The current multi‐state outbreak of the multi‐drug resistant P. aeruginosa strain has raised concerns about the safe use of other artificial products. It is high time that further trials should be conducted on other alternative strategies and evaluate the safety and efficacy of nanotechnology in the treatment of dry eye disease.